Long Term Outcomes of a Phase 1/2, Multicenter, Open-Label,...

Long Term Outcomes of a Phase 1/2, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of BMN 110 in Patients with Mucopolysaccharidosis IVA (Morquio A Syndrome)

Christian Hendriksz, Ashok Vellodi, Simon Jones, Hiwot Takkele, S. Lee, Sarah Chesler, Celeste Decker
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
105
Year:
2012
Language:
english
DOI:
10.1016/j.ymgme.2011.11.076
File:
PDF, 57 KB
english, 2012
Conversion to is in progress
Conversion to is failed